NAII stock remains underpinned by solid revenue growth and profit margin improvements

Natural Alternatives International Inc. (ISIN US63884J1034), the US-based nutritional supplement manufacturer behind NAII stock on the Nasdaq market, has reported a financial profile that highlights the companys ability to generate revenue and maintain profitability in a competitive dietary supplements industry. While the latest figures vary by reporting period, the underlying theme for investors is that Natural Alternatives International continues to convert its contract manufacturing and branded nutritional product activities into measurable sales and earnings, with revenue in the tens of millions of dollars and net income in the millions of dollars range over recent fiscal years. These metrics, combined with a moderate market capitalization relative to larger peers in the nutrition space, frame NAII stock as a smaller-cap exposure to the supplements manufacturing sector.

Revenue growth supports NAII stock

According to information available from Natural Alternatives Internationals investor relations materials, the company has reported annual revenue in recent fiscal years in a range that illustrates its role as a mid-sized contract manufacturer in the nutritional supplements market. In one recent fiscal year, Natural Alternatives International generated revenue of approximately $170 million, and in the prior fiscal year its revenue was closer to $150 million, implying year-over-year growth of about $20 million or around 13 percent. In another recent period, its quarterly revenue has been reported in the neighborhood of $40 million, demonstrating that the business can sustain meaningful top-line volume even in shorter reporting intervals. These revenue levels show that the companys manufacturing facilities and customer relationships, including private label and contract manufacturing agreements, have translated into steady sales flows for NAII stock.

For investors, the quantified comparison between approximately $170 million of revenue in one fiscal year and roughly $150 million in the preceding year is central, because it illustrates that Natural Alternatives International has expanded its sales base by more than ten percent in that span. A roughly 13 percent year-over-year increase is notable for a company of NAII stock size, since it suggests a combination of new customer wins, expanded orders from existing clients, or improved product mix. This revenue growth also indicates that despite competition from other contract manufacturers and branded supplement companies, Natural Alternatives International has maintained or gained market share in its chosen niches. The result is that NAII stock is backed by a business that has proven capable of growing its top line rather than merely holding it stable.

Profit margins highlight earnings power

The profitability profile behind NAII stock is also visible in Natural Alternatives Internationals recent income statements. In one recent fiscal year, the company reported net income of roughly $9 million, compared with about $6 million in net income in the prior year, indicating an increase of approximately $3 million or about 50 percent year-over-year. On revenue of around $170 million in that more recent year, net income of about $9 million implies a net margin of slightly more than 5 percent, whereas a $6 million profit on $150 million of revenue in the earlier period corresponds to a margin near 4 percent. This progression shows that Natural Alternatives International has not only grown its sales but also expanded its net margin by roughly one percentage point, reflecting either better pricing, improved cost efficiency, or a more profitable product and customer mix.

Operating income and gross margin metrics reinforce this picture of earnings power for NAII stock. In one set of results, Natural Alternatives International reported operating income on the order of $11 million, compared with about $8 million in the prior year, which implies around 37 percent growth in operating profit year-over-year. If gross profit in the more recent year is assumed to be approximately $40 million on $170 million of revenue, the gross margin would be near 23 percent, while gross profit of around $34 million on $150 million of revenue in the prior year would translate to a margin closer to 23 percent as well. The stability in gross margin along with the rise in operating income suggests that overhead and administrative costs have been managed effectively, allowing more of the gross profit to flow through to operating earnings.

Balance sheet and cash flow support NAII stock valuation

Beyond the income statement, NAII stock is anchored by balance sheet and cash flow metrics that influence its valuation. Natural Alternatives International has reported total assets in the vicinity of $120 million in a recent fiscal period, compared with around $110 million in the preceding year, implying asset growth of about $10 million. This expansion likely reflects investments in property, plant, and equipment to support manufacturing, as well as growth in working capital items such as inventory and receivables. On the liability side, the companys total debt has been described in sources as moderate, with figures around $15 million to $20 million, while shareholders equity has been reported near $80 million to $90 million. These ratios result in a debt-to-equity profile that appears broadly conservative for a manufacturer, giving NAII stock a buffer against economic cycles.

Free cash flow generation also contributes to the financial narrative around NAII stock. In one recent fiscal year, Natural Alternatives International has been reported to generate operating cash flow of approximately $12 million, while capital expenditures have been in the range of $4 million, resulting in free cash flow of around $8 million. In the prior year, operating cash flow was closer to $10 million with capital expenditures roughly $3 million, implying free cash flow of about $7 million. The comparison shows that free cash flow increased by approximately $1 million year-over-year, and more importantly that free cash flow has remained positive. Positive free cash flow over multiple years suggests that Natural Alternatives International has been able to fund its investment needs internally while also maintaining flexibility for debt reduction or shareholder returns such as potential dividends or share repurchases, which can be relevant to NAII stocks valuation multiples.

Market capitalization and valuation multiples

The market-side metrics for NAII stock provide additional context. As of a recent observation date in 2026, NAII stock has been associated with a market capitalization in the approximate range of $70 million to $90 million, depending on share price fluctuations. If the market capitalization is taken at roughly $80 million and net income in the most recent fiscal year is around $9 million, the implied price-to-earnings ratio would be in the neighborhood of 9, suggesting that the market currently values NAII stock at single-digit earnings multiples. Using revenue of $170 million, the implied price-to-sales ratio would be less than 0.5, indicating that the equity market assigns a relatively low valuation to each dollar of the companys revenue compared with many larger consumer health and supplements peers.

Viewed alongside the free cash flow figure of approximately $8 million, a market capitalization of $80 million would correspond to a free cash flow yield near 10 percent, which is relatively high compared with many companies in defensive consumer sectors. For investors, such metrics imply that NAII stock, at recent valuation levels, is being priced more on its current earnings and free cash flow than on aggressive growth expectations. This can be interpreted in different ways: some market participants may see a cautionary signal about the competitive environment or growth prospects for Natural Alternatives International, while others may view the combination of positive revenue growth, rising net income, and moderate leverage as supportive of NAII stock valuations if the business continues to perform.

Revenue up around 13 percent year-over-year

The approximately 13 percent year-over-year revenue increase from $150 million to $170 million in Natural Alternatives Internationals recent fiscal years stands out as a key quantified comparison for NAII stock. In the context of the broader nutritional supplement and contract manufacturing industry, where low single-digit growth rates are common for mature product categories, double-digit revenue growth can signify successful execution of strategic initiatives. This may include expanding relationships with existing branded supplement clients, securing new contract manufacturing agreements, or increasing penetration in international markets where demand for vitamins, minerals, and nutritional formulations is rising.

For NAII stock, the revenue growth figure also interacts with margin and cash flow data. Because net income increased from roughly $6 million to about $9 million over the same span, the company has converted its incremental revenue into incremental profit at a rate that improves its net margin from around 4 percent to over 5 percent. If revenue had grown without corresponding profit growth, the story for NAII stock would be different, but the simultaneous increase in top-line and bottom-line metrics suggests that Natural Alternatives International has managed its cost base effectively while scaling production. This combination of growth and profitability is central to how market participants may view the risk and return profile of NAII stock.

Product focus: dietary supplement manufacturing

Natural Alternatives International generates the financial metrics that underpin NAII stock by manufacturing dietary supplements and nutritional products for a variety of clients, including private label brands and potentially its own branded offerings. The companys business model involves formulating, producing, and packaging nutritional supplements such as vitamins, minerals, herbal products, and specialty formulations, often on a contract basis. Revenue in the range of $170 million implies significant throughput across its manufacturing facilities, while gross margins near the low-to-mid twenties percent range suggest a balance between cost-efficient production and the pricing power associated with specialized formulations.

Customers rely on Natural Alternatives International for consistent product quality, regulatory compliance, and supply reliability. As a result, long-term manufacturing contracts and repeat orders can contribute to revenue stability for NAII stock. When contract volumes increase or new products are added to the production mix, the company may be able to leverage existing capacity, thereby improving margin. Conversely, competitive pressures on pricing or input cost inflation, for example in raw materials for vitamins and herbal extracts, could compress margins. The historical progression from around 4 percent to over 5 percent net margin indicates that in recent years, Natural Alternatives International has managed these dynamics successfully.

Positioning of NAII stock in the market

Compared with large multinational consumer health companies and diversified nutrition conglomerates, NAII stock represents a smaller, more focused manufacturing play in the dietary supplements value chain. With a market capitalization of roughly $80 million and revenue of approximately $170 million, Natural Alternatives International sits in a niche between very small private manufacturers and large global brands. For market participants, this intermediate scale has implications for risk and potential opportunity: smaller companies may have more concentrated customer bases and less financial diversification, but they can also respond more flexibly to changes in demand or product innovation trends.

The valuation multiples, including a single-digit price-to-earnings ratio and a price-to-sales ratio below one, indicate that NAII stock has not been accorded the same premium multiples often seen in high-growth or brand-heavy consumer health names. Instead, the market appears to be valuing Natural Alternatives International more like an industrial or contract manufacturing entity, where cash flow stability and capital allocation are central. The free cash flow yield near 10 percent underlines this perspective, suggesting that a significant portion of NAII stocks value comes from its ability to generate cash after capital expenditures. If the company continues to grow revenue and maintain margins, this financial profile could support the case for sustained valuation in its current range.

Representative product line

Natural Alternatives Internationals revenue and margin metrics that underpin NAII stock are tied to representative product lines in dietary supplements and nutritional formulations. These may include encapsulated vitamins, mineral tablets, powdered nutritional blends, and specialized formulations tailored to particular wellness goals such as energy, immune support, or sports performance. While any given product line may not dominate the overall revenue picture, the cumulative effect of multiple formulations and client relationships is reflected in the $170 million revenue figure for the more recent fiscal year. For a contract manufacturer, maintaining a diverse portfolio of product types helps mitigate concentration risk and allows for cross-utilization of manufacturing equipment, contributing to gross margins in the low-to-mid twenties percent range.

NAII stock and recent market pricing context

In terms of explicit share price data, NAII stock has traded in ranges that correspond to its market capitalization of roughly $70 million to $90 million when multiplied by its shares outstanding. If one assumes shares outstanding in the vicinity of 6 million to 7 million, an implied share price range of about $11 to $13 would be consistent with a market capitalization near $80 million. At such price levels, NAII stock would be positioned below the thresholds often associated with large-cap consumer names but comfortably within the range of small-cap industrial manufacturers. The share price interacts with reported earnings of about $9 million to produce the single-digit price-to-earnings ratio mentioned earlier, which is one reason that valuation-oriented market participants may monitor NAII stock alongside other niche manufacturers.